SAN CARLOS, Calif., April 29, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel […]
$3,000,000 non-refundable financial assistance from Transition énergétique Québec’s Technoclimat program $1,994,405 in funding closed with Investissement Québec through two loan [...]